Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

globenewswire.com
CVAC BNTX SNY AMGN NVS PFE

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

globenewswire.com
NVS

ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider

globenewswire.com
NVS LLY

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program

businesswire.com
NVS

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

globenewswire.com
NVS

Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum

globenewswire.com
NVS LLY

BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair

globenewswire.com
PFE NVS

Bringing His On-Screen Journey to Life, Ricco Ross of Tyler Perry's Netflix Series 'Beauty in Black' Joins ZERO Prostate Cancer as Global Ambassador

prnewswire.com
NVS

Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

prnewswire.com
NVS AZN

Nasal Mucosa Therapeutics Market Forecast 2026-2036: Market to Reach USD 31.7 Billion by 2036 at 18.3% CAGR

accessnewswire.com
GSK JNJ PFE AZN APT NVS LLY